Open a section to read the detail.
Concord Biotech (CONCORDBIO) share price is tracked live on this page, with the intraday move, day range, historical chart, financial results, shareholding pattern and technical levels for both NSE and BSE.
CONCORDBIO has been listed on the NSE since 18 August 2023 and trades under ISIN INE338H01029, with a face value of ₹1. It is classified by the NSE under Healthcare.
Prices update through the trading session. Figures on this page are for information only and are not a recommendation to buy or sell.
| Company | Concord Biotech |
|---|---|
| NSE symbol | CONCORDBIO |
| Sector | Healthcare |
| ISIN | INE338H01029 |
| Listed on NSE | 18 August 2023 |
| Face value | ₹1 |
| Series | EQ (rolling settlement, intraday allowed) |
| Exchanges | NSE and BSE |
| Previous close | ₹1,461.10 |
| 52-week range | ₹987.00 – ₹1,704.00 |
The live Concord Biotech (CONCORDBIO) share price above shows the last traded price, the change and percentage change for the session, and the day's open, high, low and previous close. Use the exchange toggle to switch between the NSE and BSE quote.
The interactive chart plots CONCORDBIO across intraday, daily, weekly and monthly timeframes, so you can read the Concord Biotech share price history over any period and compare it against index or peer performance.
The financials tab carries the quarterly and annual results for Concord Biotech — revenue, operating profit, net profit and earnings per share — alongside the balance sheet and cash-flow statements, so you can follow how each CONCORDBIO result compares with earlier periods.
The shareholding pattern shows how Concord Biotech equity is split between promoters, foreign institutional investors, domestic institutions and public shareholders, with the quarter-on-quarter change in each holding as filed with the exchanges.
Corporate actions for CONCORDBIO — dividends declared and their ex-dates, along with any bonus issue, stock split or rights issue Concord Biotech has announced — are listed with the record dates the exchanges published.
Over the last year Concord Biotech (CONCORDBIO) has traded between ₹987.00 and ₹1,704.00. The 52-week range is the simplest read on where the current price sits against its own recent history.
Technical levels for CONCORDBIO include moving averages, RSI, MACD and classic, Fibonacci and Camarilla pivot tables, plus the 52-week high and low, to help frame support and resistance around the current Concord Biotech share price.
The live Concord Biotech (CONCORDBIO) price is shown at the top of this page, together with the day's change, open, high, low and previous close for both NSE and BSE. It updates through the trading session.
Concord Biotech trades on the NSE under the symbol CONCORDBIO, with ISIN INE338H01029 in the EQ series.
Concord Biotech (CONCORDBIO) has been listed on the National Stock Exchange since 18 August 2023. Its shares carry a face value of ₹1.
The financials section on this page carries Concord Biotech's quarterly and annual results, balance sheet and cash-flow statements, so you can compare each CONCORDBIO reporting period against the last.
Any dividend, bonus issue or stock split Concord Biotech has declared appears in the corporate actions section on this page, with the ex-date and record date as published by the exchanges.
The shareholding section breaks CONCORDBIO down by promoter, foreign institutional, domestic institutional and public holding, with the change from the previous quarter.
The NSE classifies Concord Biotech under Healthcare. You can compare it against other Healthcare stocks from the sector peers listed on this page.
You need a trading and demat account to buy CONCORDBIO on the NSE or BSE. Once your account is active you can place a buy or sell order from this page. Nothing here is a recommendation — please make your own assessment.